Top

Journal of Orthopaedic Surgery and Research

Published in:

01-12-2020 | osteosarcoma | Research article

Zinc promotes cell apoptosis via activating the Wnt-3a/β-catenin signaling pathway in osteosarcoma

Authors: Kai Gao, Yingchun Zhang, Jianbing Niu, Zhikui Nie, Qingsheng Liu, Chaoliang Lv

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2020

Abstract

Background

The zinc content in the blood and tumor tissues of patients with osteosarcoma and the underlying regulation and molecular mechanism of zinc have not been reported.

Methods and results

This study showed that the zinc content in the blood and tumor tissues of patients with osteosarcoma significantly reduced. CCK-8 and Transwell chamber assays revealed that zinc treatment significantly inhibited the proliferation and invasion abilities of osteosarcoma cells. Western blot analysis indicated that the expression levels of caspase-3 and caspase-9 were significantly increased, suggesting that zinc inhibited the growth and promoted the apoptosis of osteosarcoma cells. In addition, the expression levels of Wnt-3a and β-catenin, the marker proteins of the Wnt/β-catenin signaling pathways, were significantly increased in osteosarcoma cells after zinc intervention, which demonstrated that the pathway was clearly activated. However, the effect of zinc on the apoptosis, proliferation, and invasion abilities of osteosarcoma cells was reversed when the Wnt/β-catenin signaling pathways was inhibited by XAV939 (Wnt antagonist) treatment.

Conclusions

This study is the first to report the changes in zinc levels in the blood and tumor tissues of patients with osteosarcoma and to preliminarily verify that zinc inhibits the proliferation and invasion and promote the apoptosis of osteosarcoma cells by inducing the Wnt/β-catenin signaling pathway, which ultimately inhibit cancer growth.

Moore DD, Luu HH. Osteosarcoma. Cancer Treat Res. 2014;162:65–92.PubMedCrossRef

Friebele JC, et al. Osteosarcoma: a meta-analysis and review of the literature. Am J Orthop (Belle Mead NJ). 2015;44(12):547–53.

Zhou W, et al. Advances in targeted therapy for osteosarcoma. Discov Med. 2014;17(96):301–7.PubMed

Zhi LQ, et al. Identification of novel target for osteosarcoma by network analysis. Med Sci Monit. 2018;24:5914–24.PubMedPubMedCentralCrossRef

Muhamed PK, Vadstrup S. Zinc is the most important trace element. Ugeskr Laeger. 2014;176(5):V11120654.

Inoue K, O’Bryant Z, Xiong ZG. Zinc-permeable ion channels: effects on intracellular zinc dynamics and potential physiological/pathophysiological significance. Curr Med Chem. 2015;22(10):1248–57.PubMedPubMedCentralCrossRef

Bonaventura P, et al. Zinc and its role in immunity and inflammation. Autoimmun Rev. 2015;14(4):277–85.CrossRef

Ziliotto S, Ogle O, Taylor KM. Targeting zinc (II) signalling to prevent cancer. Met Ions Life Sci. 2018;18:507–29.

Qiao L, Feng Y. Intakes of heme iron and zinc and colorectal cancer incidence: a meta-analysis of prospective studies. Cancer Causes Control. 2013;24(6):1175–83.PubMedCrossRef

10.

Khayyatzadeh SS, et al. Dietary intake of zinc, serum levels of zinc and risk of gastric cancer: a review of studies. Adv Biomed Res. 2015;4:118.PubMedPubMedCentral

11.

Zamani ARN, et al. Photo-modulation of zinc phthalocyanine-treated breast cancer cell line ZR-75-1 inhibited the normal tumor activity in vitro. Lasers Med Sci. 2018;33(9):1969–78.PubMedCrossRef

12.

Wei ZZ, et al. Neuroprotective and regenerative roles of intranasal Wnt-3a administration after focal ischemic stroke in mice. J Cereb Blood Flow Metab. 2018;38(3):404–21.PubMedCrossRef

13.

Misaghi A, et al. Osteosarcoma: a comprehensive review. Sicot j. 2018;4:12.PubMedPubMedCentralCrossRef

14.

Saraf AJ, Fenger JM, Roberts RD. Osteosarcoma: accelerating progress makes for a hopeful future. Front Oncol. 2018;8:4.PubMedPubMedCentralCrossRef

15.

Zhao C, et al. An immunohistochemical study of stathmin 1 expression in osteosarcoma shows an association with metastases and poor patient prognosis. Med Sci Monit. 2018;24:6070–8.PubMedPubMedCentralCrossRef

16.

Hu F, et al. High expression of periostin is dramatically associated with metastatic potential and poor prognosis of patients with osteosarcoma. World J Surg Oncol. 2014;12:287.PubMedPubMedCentralCrossRef

17.

Pruksakorn D, et al. Survival rate and prognostic factors of conventional osteosarcoma in northern Thailand: a series from Chiang Mai University Hospital. Cancer Epidemiol. 2015;39(6):956–63.PubMedCrossRef

18.

Wang X, et al. Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):52.PubMedPubMedCentralCrossRef

19.

Wang Y, Teng JS. Increased multi-drug resistance and reduced apoptosis in osteosarcoma side population cells are crucial factors for tumor recurrence. Exp Ther Med. 2016;12(1):81–6.PubMedPubMedCentralCrossRef

20.

Zofkova I, Nemcikova P, Matucha P. Trace elements and bone health. Clin Chem Lab Med. 2013;51(8):1555–61.PubMed

21.

Haase H, Rink L. Zinc signals and immune function. Biofactors. 2014;40(1):27–40.PubMedCrossRef

22.

Krebs NF, Miller LV, Hambidge KM. Zinc deficiency in infants and children: a review of its complex and synergistic interactions. Paediatr Int Child Health. 2014;34(4):279–88.PubMedCrossRef

23.

Prasad AS. Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr. 2013;4(2):176–90.PubMedPubMedCentralCrossRef

24.

Ressnerova A, et al. Zinc and copper homeostasis in head and neck cancer: review and meta-analysis. Curr Med Chem. 2016;23(13):1304–30.PubMedCrossRef

25.

Wiesmann N, et al. Zinc overload mediated by zinc oxide nanoparticles as innovative anti-tumor agent. J Trace Elem Med Biol. 2019;51:226–34.PubMedCrossRef

26.

Zhang P, et al. Zinc enhances chemosensitivity to paclitaxel in PC3 prostate cancer cells. Oncol Rep. 2018;40(4):2269–77.PubMed

27.

Wang J, et al. Zinc oxide nanoparticles induce toxicity in CAL 27 oral cancer cell lines by activating PINK1/Parkin-mediated mitophagy. Int J Nanomedicine. 2018;13:3441–50.PubMedPubMedCentralCrossRef

28.

Grigoryan T, et al. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev. 2008;22(17):2308–41.PubMedPubMedCentralCrossRef

29.

Li Y, et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A. 2003;100(26):15853–8.PubMedPubMedCentralCrossRef

30.

Malanchi I, et al. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature. 2008;452(7187):650–3.PubMedCrossRef

31.

Zhao H, et al. Upregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/beta-catenin signaling pathway. Am J Transl Res. 2016;8(8):3503–12.PubMedPubMedCentral

32.

Xue YL, et al. Plumbagin exhibits an anti-proliferative effect in human osteosarcoma cells by downregulating FHL2 and interfering with Wnt/beta-catenin signalling. Oncol Lett. 2016;12(2):1095–100.PubMedPubMedCentralCrossRef

33.

Zhao X, et al. MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/beta-catenin signaling pathway in a DKK1-dependent manner. Oncol Rep. 2018;40(2):767–74.PubMed

34.

Jiang C, et al. Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/beta-catenin signaling. Biochem Biophys Res Commun. 2018;502(3):382–8.PubMedCrossRef

Title: Zinc promotes cell apoptosis via activating the Wnt-3a/β-catenin signaling pathway in osteosarcoma
Authors: Kai Gao
Yingchun Zhang
Jianbing Niu
Zhikui Nie
Qingsheng Liu
Chaoliang Lv
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: osteosarcoma
Osteosarcoma
Published in: Journal of Orthopaedic Surgery and Research / Issue 1/2020
Electronic ISSN: 1749-799X
DOI: https://doi.org/10.1186/s13018-020-01585-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Zinc promotes cell apoptosis via activating the Wnt-3a/β-catenin signaling pathway in osteosarcoma

Abstract

Background

Methods and results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods and results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Analysis of key genes and pathways associated with the pathogenesis of intervertebral disc degeneration

Epidermal growth factor or platelet-rich plasma combined with induced membrane technique in the treatment of segmental femur defects: an experimental study

A succinct technique for the extraction of the proximal femoral nail anti-rotation (PFNA) after unlocking failure: a case report

Modified trapdoor procedures using autogenous tricortical iliac graft without preserving the broken cartilage for treatment of osteonecrosis of the femoral head: a prospective cohort study with historical controls

Clinical application of individualized 3D-printed navigation template to children with cubitus varus deformity

Reporting and utilization of Patient-Reported Outcomes Measurement Information System® (PROMIS®) measures in orthopedic research and practice: a systematic review